Nyxoah

Belgium
Mont-Saint-Guibert, Wallonia, Belgium, 1435

Company profile

Nyxoah company profile

Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Business identity

Contact email
[email protected]
Phone number
(322)612-1755
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
1435
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
11
Total equity funding
$194.9M
Last funding
Post IPO Debt / $52.3M / 2025-11-13
Last equity funding
Post IPO Equity / $25.6M
Investors
6
Lead investors
4
Founders
2
Articles
214
Exited on
2021-07-02

Founders and investors

Founders

Adi MashiachRobert Taub

Lead investors

CochlearEuropean Investment BankGilde HealthcareViralety Ventures

Investors

CochlearEuropean Investment BankGilde HealthcareResMedS.R.I.W.